Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$52.42

-5.25 (-9.10%)

07:48
11/30/16
11/30
07:48
11/30/16
07:48

Mallinckrodt price target lowered to $70 from $92 at Leerink

Leerink analyst Jason Gerberry lowered his price target for Mallinckrodt to $70 from $92 following quarterly results due to a lack of near-term catalysts. The analyst reiterates an Outperform rating on the shares.

  • 30

    Nov

  • 02

    Dec

  • 14

    Dec

MNK Mallinckrodt
$52.42

-5.25 (-9.10%)

11/17/16
WELS
11/17/16
NO CHANGE
WELS
Outperform
Mallinckrodt drop on short-seller report a buying opportunity, says Wells Fargo
Wells Fargo analyst David Maris said the 12% drop in Mallinckrodt on the heels of a new report from short-seller Citron Research presents a buying opportunity, as he believes the assertion that Acthar has no clinical data is incorrect. Maris noted the report came out during Mallinckrodt's quiet period, which is something that had previously happened with a prior Citron report on the company, but the company tells him that the CEO's previous answer to a question regarding Acthar's exposure to Medicaid and Medicare was accurate. Maris keeps an Outperform rating on Mallinckrodt shares.
11/17/16
RAJA
11/17/16
INITIATION
Target $72
RAJA
Outperform
Mallinckrodt initiated with an Outperform at Raymond James
Raymond James initiated Mallinckrodt with an Outperform and a $72 price target.
11/18/16
RAJA
11/18/16
INITIATION
Target $72
RAJA
Outperform
Mallinckrodt initiated with an Outperform and $72 price target at Raymond James
Raymond James analyst Elliot WIlbur initiated Mallinckrodt with an Outperform and a $72 price target saying negative sector sentiment combined with further allegations from short sellers have created a compelling entry point. Wilbur believes Mallinckrodt provides one of the most sustainable top and bottom line growth trajectories in specialty pharmaceuticals and notes Achar has only a 3% penetration rate of the total addressable market, giving it a long runway of growth.
11/21/16
UBSW
11/21/16
NO CHANGE
Target $92
UBSW
Buy
Mallinckrodt weakness does not make sense, says UBS
UBS analyst Marc Goodman attended Mallinckrodt investors meetings and came away believing investors misunderstand the company story. The analyst said the company's Acthar drug, which has come under fire, has little relevance to the overall story. Goodman said the company has focused on enhancing clinical and health-economics data to help support better coverage and it is working. He said its emerging pipeline is under-appreciated. Goodman reiterated his Buy rating and $92 price target on Mallinckrodt shares.

TODAY'S FREE FLY STORIES

BOX

Box

$18.17

0.7 (4.01%)

07:47
09/25/17
09/25
07:47
09/25/17
07:47
Upgrade
Box rating change  »

Box upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

SCM

Stellus Capital

$13.63

-0.02 (-0.15%)

07:46
09/25/17
09/25
07:46
09/25/17
07:46
Initiation
Stellus Capital initiated  »

Stellus Capital initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$19.73

0.42 (2.18%)

07:46
09/25/17
09/25
07:46
09/25/17
07:46
Periodicals
KKR raises offer for Australia's Pepper Group to $543M, Reuters says »

KKR has raised its bid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSR

Versar

$0.48

0.033 (7.33%)

07:44
09/25/17
09/25
07:44
09/25/17
07:44
Hot Stocks
Breaking Hot Stocks news story on Versar »

Versar trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$88.27

2.22 (2.58%)

07:44
09/25/17
09/25
07:44
09/25/17
07:44
Recommendations
Texas Instruments analyst commentary  »

Texas Instruments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$15.64

0.62 (4.13%)

07:42
09/25/17
09/25
07:42
09/25/17
07:42
Recommendations
Pure Storage analyst commentary  »

Pure Storage price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 11

    Dec

PGR

Progressive

$47.98

0.3 (0.63%)

07:41
09/25/17
09/25
07:41
09/25/17
07:41
Recommendations
Progressive analyst commentary  »

Progressive outlook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPC

Genuine Parts

$87.98

1.63 (1.89%)

07:41
09/25/17
09/25
07:41
09/25/17
07:41
Conference/Events
Genuine Parts to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 19

    Oct

  • 30

    Oct

TFX

Teleflex

$241.77

4.71 (1.99%)

07:41
09/25/17
09/25
07:41
09/25/17
07:41
Recommendations
Teleflex analyst commentary  »

Teleflex price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

BAS

Basic Energy

$17.24

-0.34 (-1.93%)

07:41
09/25/17
09/25
07:41
09/25/17
07:41
Recommendations
Basic Energy analyst commentary  »

Basic Energy price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 16

    May

EONGY

E.ON AG

$11.19

0.2 (1.82%)

07:38
09/25/17
09/25
07:38
09/25/17
07:38
Periodicals
E.ON CFO defends plan to sell Uniper stake to Fortum, Reuters reports »

E.ON CFO Marc Spieker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

07:36
09/25/17
09/25
07:36
09/25/17
07:36
Hot Stocks
Allergan announces resignation of CFO Tessa Hilado »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

WBC

Wabco

$150.14

0.95 (0.64%)

07:36
09/25/17
09/25
07:36
09/25/17
07:36
Initiation
Wabco initiated  »

Wabco initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

FNV

Franco-Nevada

$79.32

0.4 (0.51%)

07:35
09/25/17
09/25
07:35
09/25/17
07:35
Downgrade
Franco-Nevada rating change  »

Franco-Nevada downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTN

Palatin

$0.66

0.06 (10.00%)

07:35
09/25/17
09/25
07:35
09/25/17
07:35
Earnings
Palatin reports Q4 EPS 7c, may not compare to consensus (2c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

AAPL

Apple

$151.89

-1.5 (-0.98%)

, GE

General Electric

$24.87

0.12 (0.48%)

07:35
09/25/17
09/25
07:35
09/25/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

AAPL

Apple

$151.89

-1.5 (-0.98%)

GE

General Electric

$24.87

0.12 (0.48%)

ORCL

Oracle

$48.16

0.19 (0.40%)

M

Macy's

$21.53

0.37 (1.75%)

COP

ConocoPhillips

$49.08

0.39 (0.80%)

FCAU

Fiat Chrysler

$17.95

0.58 (3.34%)

WETF

WisdomTree

$9.25

0.23 (2.55%)

KBH

KB Home

$20.88

0.1 (0.48%)

MDR

McDermott

$7.01

0.1 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

ONCE

Spark Therapeutics

$85.15

-1.95 (-2.24%)

07:33
09/25/17
09/25
07:33
09/25/17
07:33
Hot Stocks
Spark Therapeutics appoints Dr. Federico Mingozzi as Chief Scientific Officer »

Spark Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 12

    Oct

  • 12

    Jan

AGN

Allergan

$204.65

1.99 (0.98%)

07:32
09/25/17
09/25
07:32
09/25/17
07:32
Hot Stocks
Allergan announces new $2B share repurchase plan, affirms guidance »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

ECA

Encana

$11.25

-0.05 (-0.44%)

07:31
09/25/17
09/25
07:31
09/25/17
07:31
Recommendations
Encana analyst commentary  »

Encana price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$204.65

1.99 (0.98%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Allergan »

Allergan announces new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

, ROK

Rockwell Automation

$177.55

0.22 (0.12%)

07:30
09/25/17
09/25
07:30
09/25/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

EXAS

Exact Sciences

$45.96

0.96 (2.13%)

ROK

Rockwell Automation

$177.55

0.22 (0.12%)

DVA

DaVita

$57.49

-3.77 (-6.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

, GOOG

Alphabet

$928.53

-3.92 (-0.42%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Periodicals
Nintendo adds two-factor authentication for accounts, the Verge says »

Nintendo (NTDOY) users…

NTDOY

Nintendo

$45.62

-0.98 (-2.10%)

GOOG

Alphabet

$928.53

-3.92 (-0.42%)

GOOGL

Alphabet Class A

$943.26

-4.29 (-0.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

EGO

Eldorado Gold

$2.26

0.02 (0.89%)

07:29
09/25/17
09/25
07:29
09/25/17
07:29
Upgrade
Eldorado Gold rating change  »

Eldorado Gold upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

APRN

Blue Apron

$5.19

-0.04 (-0.76%)

07:28
09/25/17
09/25
07:28
09/25/17
07:28
Initiation
Blue Apron initiated  »

Blue Apron initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$188.30

0.39 (0.21%)

07:27
09/25/17
09/25
07:27
09/25/17
07:27
Recommendations
Thermo Fisher analyst commentary  »

Thermo Fisher price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.